Rhythm Pharmaceuticals (RYTM) Revenue Growth (1y) (2022 - 2026)
Rhythm Pharmaceuticals (RYTM) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | - |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | 96.43% |
| 10 | Rhythm Pharmaceuticals | 7.28 Bn | 6.94 Bn | 52.96 Mn | 83.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.81% |
| Dec 31, 2025 | 36.87% |
| Sep 30, 2025 | 54.28% |
| Jun 30, 2025 | 66.80% |
| Mar 31, 2025 | 25.94% |
| Dec 31, 2024 | 72.61% |
| Sep 30, 2024 | 47.76% |
| Jun 30, 2024 | 51.28% |
| Mar 31, 2024 | 126.41% |
| Dec 31, 2023 | 401.12% |
| Sep 30, 2023 | 425.30% |
| Jun 30, 2023 | 112.01% |
| Mar 31, 2023 | 665.62% |
| Dec 31, 2022 | -542.93% |
| Sep 30, 2022 | 316.73% |
| Jun 30, 2022 | 3,208.76% |
| Mar 31, 2022 | 4,180.00% |